A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects

被引：0
|
作者：
Ippei Ikushima
Lene Jensen
Anne Flint
Tomoyuki Nishida
Jeppe Zacho
Shin Irie
机构：
[1] LTA Sumida Hospital,
[2] Novo Nordisk A/S,undefined
[3] Novo Nordisk Pharma Ltd,undefined
[4] SOUSEIKAI Global Clinical Research Center,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
GLP-1 receptor agonist; Japanese subjects; Pharmacodynamics; Pharmacokinetics; Semaglutide; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 544
页数：13
相关论文
共 50 条
  • [1] A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects
    Ikushima, Ippei
    Jensen, Lene
    Flint, Anne
    Nishida, Tomoyuki
    Zacho, Jeppe
    Irie, Shin
    ADVANCES IN THERAPY, 2018, 35 (04) : 531 - 544
  • [2] Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial
    Shi, Aixin
    Xie, Panpan
    Nielsen, Lasse Lykke
    Skjoth, Trine Vang
    He, Xuemei
    Haugaard, Sine Pfeiffer
    ADVANCES IN THERAPY, 2021, 38 (01) : 550 - 561
  • [3] Pharmacokinetics, Safety and Tolerability of Once-Weekly Subcutaneous Semaglutide in Healthy Chinese Subjects: A Double-Blind, Phase 1, Randomized Controlled Trial
    Aixin Shi
    Panpan Xie
    Lasse Lykke Nielsen
    Trine Vang Skjøth
    Xuemei He
    Sine Pfeiffer Haugaard
    Advances in Therapy, 2021, 38 : 550 - 561
  • [4] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
    Daniela Willen
    Wolfgang Uhl
    Peter Wolna
    Orestis Papasouliotis
    Özkan Yalkinoglu
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 27 - 40
  • [5] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
    Willen, Daniela
    Uhl, Wolfgang
    Wolna, Peter
    Papasouliotis, Orestis
    Yalkinoglu, Oezkan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (01) : 27 - 40
  • [6] Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once-weekly basal insulin, in healthy participants: A randomized trial
    Tang, Chengyong
    Su, Rui
    Wan, Lei
    Zhu, Mingxue
    Pu, Junliang
    Hao, Chunyue
    Zhao, Jing
    He, Anshun
    Xie, Tian
    Li, Yue
    Chen, Wei
    Gan, Zhong-Ru
    DIABETES OBESITY & METABOLISM, 2025,
  • [7] Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects
    Mai Shibata
    Toshifumi Hatta
    Masako Saito
    Junko Toyoshima
    Yuichiro Kaneko
    Kazuo Oda
    Tetsuya Nishimura
    Clinical Drug Investigation, 2020, 40 : 469 - 484
  • [8] Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects
    Shibata, Mai
    Hatta, Toshifumi
    Saito, Masako
    Toyoshima, Junko
    Kaneko, Yuichiro
    Oda, Kazuo
    Nishimura, Tetsuya
    CLINICAL DRUG INVESTIGATION, 2020, 40 (05) : 469 - 484
  • [9] A Randomized Clinical Trial of Safety, Pharmacokinetics, and Pharmacodynamics of Weekly Dosing Supagutide in Healthy Chinese Subjects
    Ma, Anran
    Zhou, Yue
    Lou, Yan-Ru
    Liao, Yijing
    Shao, Anna
    Wang, Zhihong
    Jiang, Yaojing
    Cui, Qiaoli
    Zhao, Ying
    Li, Jia
    PruD'Homme, Gerald J.
    Zhu, Dalong
    Wang, Qinghua
    DIABETES, 2022, 71
  • [10] Safety, tolerability, pharmacokinetics (PK) / pharmacodynamics (PD) of single escalating doses of semaglutide, a unique once weekly GLP-1 analogue, in healthy male subjects
    Kapitza, C.
    Lynge, J.
    Duering, M.
    Jensen, C.
    DIABETOLOGIA, 2012, 55 : S341 - S341
12345